Cencora Income After Taxes 2010-2025 | COR
Cencora annual/quarterly income after taxes history and growth rate from 2010 to 2025. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
- Cencora income after taxes for the quarter ending March 31, 2025 was $0.717B, a 70.32% increase year-over-year.
- Cencora income after taxes for the twelve months ending March 31, 2025 was $1.706B, a 7.89% decline year-over-year.
- Cencora annual income after taxes for 2024 was $1.519B, a 12.31% decline from 2023.
- Cencora annual income after taxes for 2023 was $1.733B, a 3.96% increase from 2022.
- Cencora annual income after taxes for 2022 was $1.667B, a 7.89% increase from 2021.
| Cencora Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2024 | $1,519 |
| 2023 | $1,733 |
| 2022 | $1,667 |
| 2021 | $1,545 |
| 2020 | $-3,400 |
| 2019 | $854 |
| 2018 | $1,616 |
| 2017 | $364 |
| 2016 | $1,428 |
| 2015 | $-138 |
| 2014 | $282 |
| 2013 | $493 |
| 2012 | $761 |
| 2011 | $697 |
| 2010 | $630 |
| 2009 | $512 |
| Cencora Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2025-03-31 | $717 |
| 2024-12-31 | $494 |
| 2024-09-30 | $7 |
| 2024-06-30 | $488 |
| 2024-03-31 | $421 |
| 2023-12-31 | $603 |
| 2023-09-30 | $349 |
| 2023-06-30 | $479 |
| 2023-03-31 | $428 |
| 2022-12-31 | $476 |
| 2022-09-30 | $299 |
| 2022-06-30 | $363 |
| 2022-03-31 | $555 |
| 2021-12-31 | $449 |
| 2021-09-30 | $436 |
| 2021-06-30 | $295 |
| 2021-03-31 | $434 |
| 2020-12-31 | $379 |
| 2020-09-30 | $-4,845 |
| 2020-06-30 | $287 |
| 2020-03-31 | $971 |
| 2019-12-31 | $187 |
| 2019-09-30 | $132 |
| 2019-06-30 | $302 |
| 2019-03-31 | $28 |
| 2018-12-31 | $392 |
| 2018-09-30 | $194 |
| 2018-06-30 | $278 |
| 2018-03-31 | $282 |
| 2017-12-31 | $862 |
| 2017-09-30 | $-345 |
| 2017-06-30 | $50 |
| 2017-03-31 | $411 |
| 2016-12-31 | $247 |
| 2016-09-30 | $146 |
| 2016-06-30 | $349 |
| 2016-03-31 | $603 |
| 2015-12-31 | $330 |
| 2015-09-30 | $361 |
| 2015-06-30 | $214 |
| 2015-03-31 | $-513 |
| 2014-12-31 | $-200 |
| 2014-09-30 | $66 |
| 2014-06-30 | $-13 |
| 2014-03-31 | $180 |
| 2013-12-31 | $49 |
| 2013-09-30 | $51 |
| 2013-06-30 | $64 |
| 2013-03-31 | $204 |
| 2012-12-31 | $175 |
| 2012-09-30 | $192 |
| 2012-06-30 | $190 |
| 2012-03-31 | $219 |
| 2011-12-31 | $160 |
| 2011-09-30 | $138 |
| 2011-06-30 | $184 |
| 2011-03-31 | $214 |
| 2010-12-31 | $161 |
| 2010-09-30 | $134 |
| 2010-06-30 | $163 |
| 2010-03-31 | $181 |
| 2009-12-31 | $151 |
| 2009-09-30 | $130 |
| 2009-06-30 | $125 |
| 2009-03-31 | $144 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $54.879B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.784B | 25.47 |
| Elevance Health (ELV) | United States | $91.409B | 11.80 |
| CVS Health (CVS) | United States | $84.718B | 10.53 |
| DiDi Global (DIDIY) | China | $20.661B | 31.36 |
| Natera (NTRA) | United States | $20.542B | 0.00 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| Solventum (SOLV) | United States | $12.150B | 12.86 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.973B | 0.00 |
| Doximity (DOCS) | United States | $11.050B | 57.47 |
| CochLear (CHEOY) | Australia | $10.944B | 0.00 |
| ICON (ICLR) | Ireland | $10.818B | 10.06 |
| Revvity (RVTY) | United States | $10.756B | 18.51 |
| Viatris (VTRS) | United States | $10.293B | 3.54 |
| Medpace Holdings (MEDP) | United States | $8.508B | 22.60 |
| Sonic Healthcare (SKHHY) | Australia | $8.280B | 0.00 |
| Avantor (AVTR) | United States | $8.191B | 11.90 |
| HealthEquity (HQY) | United States | $7.819B | 38.47 |
| Charles River Laboratories (CRL) | United States | $6.817B | 13.36 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $3.982B | 23.48 |
| BrightSpring Health Services (BTSG) | United States | $3.976B | 36.81 |
| Sotera Health (SHC) | United States | $3.727B | 21.18 |
| Alignment Healthcare (ALHC) | United States | $2.991B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.841B | 32.59 |
| Concentras Parent (CON) | United States | $2.743B | 15.85 |
| Organon (OGN) | United States | $2.264B | 2.41 |
| Premier (PINC) | United States | $2.106B | 14.42 |
| Ardent Health Partners (ARDT) | United States | $2.077B | 8.85 |
| Progyny (PGNY) | United States | $1.815B | 39.98 |
| GeneDx Holdings (WGS) | United States | $1.687B | 64.99 |
| GoodRx Holdings (GDRX) | United States | $1.657B | 30.86 |
| PACS (PACS) | United States | $1.590B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.248B | 9.50 |
| Teladoc Health (TDOC) | United States | $1.247B | 0.00 |
| Agilon Health (AGL) | United States | $1.196B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.978B | 0.00 | |
| CareDx (CDNA) | United States | $0.855B | 13.36 |
| AMN Healthcare Services Inc (AMN) | United States | $0.840B | 7.89 |
| Embecta (EMBC) | United States | $0.696B | 4.71 |
| QDM (QDMI) | Hong Kong, SAR China | $0.690B | 0.00 |
| Nutex Health (NUTX) | United States | $0.667B | 13.08 |
| Enhabit (EHAB) | United States | $0.521B | 42.83 |
| Auna S.A (AUNA) | Luxembourg | $0.508B | 13.45 |
| InnovAge Holding (INNV) | United States | $0.491B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.466B | 0.00 |
| LifeMD (LFMD) | United States | $0.375B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.352B | 0.00 |
| SBC Medicals (SBC) | United States | $0.345B | 0.00 |
| Beauty Health (SKIN) | United States | $0.234B | 0.00 |
| Oncology Institute (TOI) | United States | $0.212B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.195B | 0.00 |
| DocGo (DCGO) | United States | $0.143B | 23.33 |
| Basel Medical Group (BMGL) | Singapore | $0.088B | 0.00 |
| So-Young (SY) | China | $0.086B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.082B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.076B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.054B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.029B | 0.00 |
| KindlyMD (KDLY) | United States | $0.023B | 0.00 |
| ModivCare (MODV) | United States | $0.017B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |